Women’s Health, Hormones, and the Nervous System: What’s Been Overlooked

Women’s Health, Hormones, and the Nervous System: What’s Been Overlooked

Women are more likely than men to experience chronic symptoms that defy easy diagnosis.

Fatigue, dizziness, heart palpitations, gut issues, sleep disruption, anxiety-like sensations, temperature intolerance, and brain fog are commonly reported. Yet women are also more likely to be told that these symptoms are hormonal, stress-related, or psychological, especially when standard tests appear normal.

Increasingly, evidence points to a different explanation. Many of these symptoms reflect autonomic nervous system dysregulation, a physiological process that has been historically under-measured and under-discussed in women’s health.

The nervous system as the hormonal “master switch”

Hormones are often treated as isolated chemical messengers. In reality, they are tightly regulated by the autonomic nervous system.

The autonomic nervous system controls the organs that produce hormones and modulates how tissues respond to them. Estrogen, progesterone, cortisol, insulin, thyroid hormones, and reproductive hormones all interact continuously with sympathetic and parasympathetic signaling.

When autonomic regulation is balanced, hormonal fluctuations are tolerated well. When regulation is impaired, the same hormonal changes can trigger widespread symptoms.

This helps explain why “normal” hormone levels do not always correlate with how a woman feels. Hormonal imbalance often reflects upstream regulatory dysfunction, not primary gland failure.

Why women are uniquely vulnerable to dysregulation

Women experience more frequent and pronounced physiological transitions across the lifespan. Puberty, menstrual cycles, pregnancy, postpartum recovery, perimenopause, and menopause all require continuous autonomic adaptation.

Several factors increase vulnerability:

Cardiovascular mechanics: On average, women have smaller hearts. When vascular tone is impaired, maintaining blood flow requires higher heart rates. If sympathetic signaling fails to constrict blood vessels properly, compensatory tachycardia can become extreme, as seen in conditions like POTS.

Immune and inflammatory burden: Estrogen modulates immune function. Autoimmune and inflammatory conditions, which can damage autonomic nerves, are significantly more common in women.

Cumulative stressors: Multiple pregnancies and repeated hormonal shifts can “reset” autonomic regulation into maladaptive patterns, such as persistent parasympathetic excess.

These factors help explain why dysautonomia, autoimmune disease, chronic fatigue syndromes, and pain conditions disproportionately affect women.

When symptoms are mislabeled as anxiety

Many women with autonomic dysfunction are told their symptoms are anxiety-related.

While emotional health matters, this framing is often incomplete.

Autonomic dysfunction can produce physical anxiety without anxious thoughts. Palpitations, tremors, air hunger, dizziness, and a sense of impending doom can arise from impaired blood flow or compensatory adrenaline release rather than psychological distress.

When the nervous system fails to maintain cerebral perfusion, the brain triggers emergency catecholamine release to preserve consciousness. This “adrenaline storm” feels identical to panic but originates from physiological survival mechanisms.

Without measuring autonomic function, cause and consequence are easily confused. Treating the underlying regulatory imbalance has been shown to significantly reduce anxiety-like symptoms, confirming their physiological origin.

Pregnancy, postpartum, and long-term effects

Pregnancy places extraordinary demands on autonomic regulation.

Blood volume expands, vascular tone shifts, and hormonal signaling changes rapidly. The nervous system must continuously adapt to maintain cardiac output and blood pressure, especially in late pregnancy when venous return is mechanically compromised.

For most women, regulation recovers postpartum. For others, autonomic balance remains altered.

Conditions such as pre-eclampsia and pregnancy-induced hypertension are associated with higher long-term cardiovascular risk. Autonomic dysregulation is increasingly recognized as a contributing factor, even when routine postpartum testing appears normal.

Multiple pregnancies are also associated with persistent parasympathetic excess, which can manifest as chronic fatigue, depression-like symptoms, and metabolic difficulty long after delivery.

Menopause as a regulatory transition

Menopause is often framed purely as an endocrine event. In reality, it is also a major autonomic transition.

As estrogen declines, protective modulation of vascular tone, inflammation, and autonomic balance is reduced. This shift can unmask latent sympathetic excess or regulatory instability.

Hot flashes, night sweats, sleep disruption, and palpitations reflect changes in autonomic signaling as much as hormone levels themselves. The wide variation in symptom severity between women highlights that regulation, not hormone concentration alone, determines experience.

Extreme examples such as stress-induced cardiomyopathy (Takotsubo syndrome), which occurs predominantly in post-menopausal women, illustrate how loss of autonomic buffering can have dramatic cardiovascular consequences.

Why traditional testing often fails women

Most women’s health testing relies on static measurements. Hormone panels, resting vitals, and imaging capture snapshots, not regulation.

The autonomic nervous system is dynamic. Dysfunction often appears only during challenges such as standing, breathing changes, or stress. Patterns like sympathetic withdrawal or parasympathetic excess are invisible at rest.

A woman may have normal blood pressure sitting down yet fail to maintain cerebral perfusion when upright. She may have “normal” hormone levels while her nervous system is unable to adapt across cycles or stressors.

This mismatch between lived experience and test results is not imaginary. It reflects a measurement gap.

From dismissal to data

Objective autonomic testing can be transformative for women.

It shifts the conversation from whether symptoms are real to how regulation is functioning. It provides physiological explanations for why symptoms fluctuate, cluster, and persist across life stages.

Rather than fragmenting care across hormones, mental health, and individual organs, autonomic assessment offers a unifying framework that reflects how the body actually operates.

Rethinking women’s health

Women’s health has long been divided into silos. Autonomic health reconnects them.

It recognizes that regulation underlies hormonal balance, cardiovascular stability, immune resilience, and recovery. Measuring it brings clarity where assumptions once stood.

Understanding regulation does not replace gynecologic or endocrine care. It completes it.

Autonomic testing is coming soon

At-home autonomic testing is currently in development.

You can sign up on our website to be notified when testing becomes available and learn how your nervous system is responding to hormonal and life-stage transitions.

Understanding regulation changes everything.

References

Colombo J, Arora RR, DePace NL, Vinik AI. Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer, 2014.

DePace NL, Colombo J. Clinical Autonomic and Mitochondrial Disorders: Diagnosis, Prevention, and Treatment for Mind-Body Wellness. Springer, 2019.

Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation, and cardiovascular disease. Journal of Diabetes Investigation. 2013.

Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabetic Medicine. 2011.

DePace NL, Colombo J. Ehlers-Danlos Syndrome and autonomic dysregulation. Cardiology: Open Access. 2022.

Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome. Clinical Autonomic Research. 2021.

Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction. Journal of the American College of Cardiology. 2019.

Read more